Losartan recall - Legacy Pharmaceuticals

April 30, 2019

Express Scripts did NOT dispense any lots impacted by this recall.

On April 25th 2019, Legacy Pharmaceuticals announced an expansion of their recall of Losartan 50mg Tablets to a total of 4 lots due to the detection of an unexpected impurity found in the active pharmaceutical ingredient manufactured by Hetero Labs Limited.

Additional information is available on the FDA's website:


Last updated: March 13, 2020

The information on this site is not intended to take the place of your doctor or other healthcare professionals. It is a resource to help you make the best decisions and get the most from the medical services available to you. A licensed physician should be consulted for diagnosis and treatment of all medical conditions.